What meropenem dose should be given to an 81-year-old female (60 kg, 160 cm) with sepsis and acute kidney injury superimposed on chronic kidney disease, current serum creatinine 133 µmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Meropenem Dosing in Sepsis with AKI on CKD

For this 81-year-old female with sepsis and renal impairment (sCr 133 µmol/L, improving from 148), administer meropenem 1000 mg loading dose immediately, followed by 500 mg every 12 hours as intermittent infusions.

Rationale and Dosing Algorithm

Step 1: Calculate Creatinine Clearance

Using the Cockcroft-Gault equation for this patient 1:

  • Weight: 60 kg
  • Age: 81 years
  • sCr: 133 µmol/L = 1.5 mg/dL
  • Female correction factor: 0.85

CrCl = 0.85 × [60 × (140-81)] / (72 × 1.5) = 0.85 × 32.8 = ~28 mL/min

This places her in the 26-50 mL/min category per FDA labeling 1.

Step 2: Apply FDA-Approved Renal Dosing

According to the FDA label, for CrCl 26-50 mL/min 1:

  • Dose: Recommended dose (1 gram for sepsis/intra-abdominal infection)
  • Interval: Every 12 hours

Step 3: Incorporate Loading Dose Strategy

The French critical care guidelines strongly recommend a loading dose for all critically ill patients, independent of renal function 2. The loading dose should equal the standard intermittent dose (1 gram for sepsis), followed immediately by adjusted maintenance dosing based on creatinine clearance.

This is critical because:

  • Volume of distribution is increased in sepsis
  • Delayed achievement of therapeutic concentrations without loading dose has been associated with worse outcomes 2
  • The loading dose addresses the initial distribution phase, while maintenance dosing is adjusted for clearance

Administration Details

Loading Dose:

  • 1000 mg IV over 15-30 minutes 1

Maintenance Dosing:

  • 500 mg IV every 12 hours (not every 8 hours due to renal impairment)
  • Infuse over 15-30 minutes 1

Critical Considerations

Improving Renal Function

Her creatinine is improving (148→133 µmol/L). Monitor daily:

  • If CrCl increases to >50 mL/min: escalate to 1000 mg every 8 hours
  • If CrCl decreases to 10-25 mL/min: reduce to 500 mg every 12 hours
  • If CrCl <10 mL/min: reduce to 500 mg every 24 hours 1

Elderly Patient Factors

At 81 years, she requires careful monitoring 1:

  • Meropenem is renally excreted; elderly patients have higher risk of accumulation
  • No dose adjustment beyond renal function is needed for age alone
  • The calculated CrCl already accounts for age-related decline

Measurement vs. Estimation of Renal Function

If possible, obtain a measured 24-hour creatinine clearance 3. Recent evidence shows that eGFR equations (CKD-EPI, MDRD, Cockcroft-Gault) can significantly over- or underestimate actual clearance in critically ill patients, leading to inappropriate dosing. However, in the absence of measured CrCl, the Cockcroft-Gault calculation provides the FDA-validated approach for dose adjustment 1.

Therapeutic Drug Monitoring

Consider TDM if available 2, particularly because:

  • She has AKI on CKD (unpredictable pharmacokinetics)
  • Target: free drug concentration >4× MIC for 100% of dosing interval
  • Critical illness causes significant PK variability

Continuous vs. Intermittent Infusion

While continuous infusion may optimize PK/PD targets 2, meropenem has limited stability (6-12 hours at 25°C) 2, making intermittent dosing more practical in most settings. Extended infusions (3-hour infusions every 12 hours) could be considered if standard dosing fails to achieve clinical response.

Common Pitfalls to Avoid

  1. Omitting the loading dose: This is the most critical error—always give 1000 mg loading dose regardless of renal function 2

  2. Using standard 8-hour dosing: With CrCl ~28 mL/min, every 8-hour dosing will cause accumulation and potential neurotoxicity

  3. Relying solely on age for dosing: Dose adjustment must be based on measured/calculated renal function, not age 4

  4. Underdosing in improving AKI: Her improving creatinine suggests recovering renal function—reassess daily and escalate dose if CrCl normalizes

  5. Ignoring the sepsis indication: For sepsis/intra-abdominal infection, the target dose is 1 gram (not 500 mg used for skin infections) 1, adjusted by interval for renal impairment

References

Related Questions

In a patient with an intra‑abdominal abscess, acute kidney injury, elevated alanine aminotransferase and bilirubin, hypoalbuminemia, and leukocytosis who is receiving meropenem and metronidazole, how should the antibiotic doses be adjusted and what is the recommended duration of therapy?
What is the appropriate meropenem dose for a 76-year-old male, weight 95 kg, height 175‑180 cm, serum creatinine 134 µmol/L, post‑spine fracture surgery, febrile with urine Escherichia coli and blood gram‑positive cocci, currently on piperacillin‑tazobactam (Tazocin) empirically?
What is the recommended dosing interval for meropenem in an adult with normal renal function?
What is the recommended meropenem dosing regimen for an adult with normal renal function, including adjustments for renal impairment and typical treatment duration?
What are the indications, dosing regimens (including renal adjustments), administration method, treatment duration, monitoring parameters, and alternative therapies for meropenem?
Can empagliflozin be initiated in a patient with an estimated glomerular filtration rate of 42 mL/min/1.73 m², and what starting dose is recommended?
How should I prepare a vasopressin solution by diluting 20 units in 50 mL of sterile diluent?
When should antibiotics be used for oral ulcers and what is the appropriate antibiotic regimen?
What is the recommended duration of dual antiplatelet therapy for an acute ischemic stroke caused by arterial embolism?
What is the appropriate treatment for deep venous insufficiency and how should a high Wells score for deep‑vein thrombosis be managed in primary care?
What is the recommended protocol for tapering vasopressin infusion in a hemodynamically stable patient without active bleeding or severe adrenal insufficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.